Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Psychedelic Medicine 2 Volumes PDF full book. Access full book title Psychedelic Medicine 2 Volumes.
| Author | : Michael J. Winkelman |
| Publisher | : Praeger |
| Total Pages | : 0 |
| Release | : 2007-06-30 |
| Genre | : Psychology |
| ISBN | : 0275990230 |
A collection of essays examining the current status of the therapeutic potential of hallucinogenic substances, exploring how the drugs can be used to effectively treat a wide range of conditions.
| Author | : Charles S. Grob |
| Publisher | : Guilford Publications |
| Total Pages | : 602 |
| Release | : 2023-01-13 |
| Genre | : Medical |
| ISBN | : 1462551890 |
This handbook reviews promising applications of psychedelics in treatment of such challenging psychiatric problems as posttraumatic stress disorder, major depression, substance use disorders, and end-of-life anxiety. Experts from multiple disciplines synthesize current knowledge on psilocybin, MDMA, ketamine, and other medical hallucinogens. The volume comprehensively examines these substances' neurobiological mechanisms, clinical effects, therapeutic potential, risks, and anthropological and historical contexts. Coverage ranges from basic science to practical clinical considerations, including patient screening and selection, dosages and routes of administration, how psychedelic-assisted sessions are structured and conducted, and management of adverse reactions.
| Author | : Richard Louis Miller |
| Publisher | : Simon and Schuster |
| Total Pages | : 256 |
| Release | : 2017-11-21 |
| Genre | : Body, Mind & Spirit |
| ISBN | : 1620556987 |
Explores the potential of psychedelics as medicine and the intersections of politics, science, and psychedelics • Explores the tumultuous history of psychedelic research, the efforts to restore psychedelic therapies, and the links between psychiatric drugs and mental illness • Offers non-technical summaries of the most recent, double-blind, placebo-controlled studies with MDMA, psilocybin, LSD, and ayahuasca • Includes the work of Rick Doblin, Stanislav Grof, James Fadiman, Julie Holland, Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker Embracing the revival of psychedelic research and the discovery of new therapeutic uses, clinical psychologist Dr. Richard Louis Miller discusses what is happening today in psychedelic medicine--and what will happen in the future--with top researchers and thinkers in this field, including Rick Doblin, Stanislav Grof, James Fadiman, Julie Holland, Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker. Dr. Miller and his contributors cover the tumultuous history of early psychedelic research brought to a halt 50 years ago by the U.S. government as well as offering non-technical summaries of the most recent studies with MDMA, psilocybin, LSD, and ayahuasca. They explore the biochemistry of consciousness and the use of psychedelics for self-discovery and healing. They discuss the use of psilocybin for releasing fear in the terminally ill and the potential for MDMA-assisted psychotherapy in the treatment of PTSD. They examine Dr. Charles Grob’s research on the indigenous use and therapeutic properties of ayahuasca and Dr. Gabor Mate’s attempt to transport this plant medicine to a clinical setting with the help of Canada’s Department of National Health. Dr. Miller and his contributors explore the ongoing efforts to restore psychedelic therapies to the health field, the growing threat of overmedication by the pharmaceutical industry, and the links between psychiatric drugs and mental illness. They also discuss the newly shifting political climate and the push for new research, offering hope for an end to the War on Drugs and a potential renaissance of research into psychedelic medicines around the world.
| Author | : Adam L. Halberstadt |
| Publisher | : Springer |
| Total Pages | : 430 |
| Release | : 2018-03-27 |
| Genre | : Medical |
| ISBN | : 3662558807 |
This volume brings together the latest basic and clinical research examining the effects and underlying mechanisms of psychedelic drugs. Examples of drugs within this group include LSD, psilocybin, and mescaline. Despite their structural differences, these compounds produce remarkably similar experiences in humans and share a common mechanism of action. Commonalities among the substances in this family are addressed both at the clinical and phenomenological level and at the basic neurobiological mechanism level. To the extent possible, contributions relate the clinical and preclinical findings to one another across species. The volume addresses both the risks associated with the use of these drugs and the potential medical benefits that might be associated with these and related compounds.
| Author | : James Adams |
| Publisher | : Elsevier Health Sciences |
| Total Pages | : 3163 |
| Release | : 2010-01-01 |
| Genre | : Health & Fitness |
| ISBN | : 0323054722 |
This reference places the latest information at users' fingertips, and a more streamlined format makes it easy to find the exact information quickly and conveniently. Includes access to a companion Web site for additional resources.
| Author | : Victor R. Preedy |
| Publisher | : Academic Press |
| Total Pages | : 1182 |
| Release | : 2016-03-25 |
| Genre | : Psychology |
| ISBN | : 0128003758 |
Neuropathology of Drug Addictions and Substance Misuse, Volume 2: Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects is the second of three volumes in this informative series and offers a comprehensive examination of the adverse consequences of the most common drugs of abuse. Each volume serves to update the reader’s knowledge on the broader field of addiction as well as to deepen understanding of specific addictive substances. Volume 2 addresses stimulants, club and dissociative drugs, hallucinogens, and inhalants and solvents. Each section provides data on the general, molecular and cellular, and structural and functional neurological aspects of a given substance, with a focus on the adverse consequences of addictions. Research shows that the neuropathological features of one addiction are often applicable to those of others, and understanding these commonalties provides a platform for studying specific addictions in more depth and may ultimately lead researchers toward new modes of understanding, causation, prevention, and treatment. However, marshalling data on the complex relationships between addictions is difficult due to the myriad material and substances. Offers a modern approach to understanding the pathology of substances of abuse, offering an evidence-based ethos for understanding the neurology of addictions Fills an existing gap in the literature by serving as a “one-stop-shopping synopsis of everything to do with the neuropathology of drugs of addiction and substance misuse Includes in each chapter: list of abbreviations, abstract, introduction, applications to other addictions and substance misuse, mini-dictionary of terms, summary points, 6+ figures and tables, and full references Offers coverage of preclinical, clinical, and population studies, from the cell to whole organs, and from the genome to whole body
| Author | : Ben Sessa |
| Publisher | : Mercury Learning and Information |
| Total Pages | : 60 |
| Release | : 2016-02-29 |
| Genre | : Medical |
| ISBN | : 193758559X |
Psychedelic Drug Treatments: Assisting the Therapeutic Process provides information about current and quite viable investigation into reviving and progressing with neurological research that began in the middle of the 20th century and was brought to a halt when certain drugs were banned in the 1970s. Using a question/answer format, the book will introduce you to the way in which the chemical compounds known as psychedelics affect the brain, provide you with the definitions of key terms particular to the neurological and psychological vocabulary, describe the specific disorders that can realistically be helped or relieved through treatment with psychedelics, and offer information with regard to current research being conducted in the field. This text will discuss the history of the earlier research efforts and will examine the likelihood of a resurgence of interest in the successful development of methods and practices of clinical therapy assisted by psychedelic drugs. The purpose of this volume is to promote an understanding of the use of psychedelics as tools to assist therapy and to challenge the 40-year-old prejudices against research into the possible benefits of these drugs. Features: •Questions and answers about the history, research, and treatments related to psychedelic drugs •Makes a case for the re-evaluation of psychedelics — LSD, MDMA (‘ecstasy’), DMT, psilocybin, ayahuasca, peyote, ibogaine, and more — and their clinical potential for treating a range of conditions from post-traumatic stress disorder and depression to autism and cluster headaches. •Includes numerous in-text resources such as links to Web sites, videos, articles, blogs, etc. from NIH, FDA, YouTube, and university/clinical studies
| Author | : Aeternum |
| Publisher | : |
| Total Pages | : 330 |
| Release | : 2018-11-22 |
| Genre | : |
| ISBN | : 9780692197905 |
The Psychedelic Anthology is a seven-part anthology and collection of real-life psychedelic experiences shared from all over the world. This anthology challenges the negative stigma surrounding sacred medicines such as LSD, Ayahuasca, and Mescaline by sharing the very profound and transformative experiences that may occur while under the influence of these substances, many of which have been used as sacraments in religious and spiritual ceremonies for millennia to heal and connect with the divine. Through these incredibly powerful stories, this book series hopes to humanize these medicines and reintroduce their importance to mankind.
| Author | : J. Harold Ellens |
| Publisher | : Bloomsbury Publishing USA |
| Total Pages | : 499 |
| Release | : 2015-08-18 |
| Genre | : Health & Fitness |
| ISBN | : |
Edited by two preeminent scholars, this book provides coverage of the policy issues related to the increasingly diverse treatments, practices, and applications of psychedelics. Hallucinogenic substances like LSD, mescaline, peyote, MDMA, and ayahuasca have a reputation as harmful substances that are enjoyed only by recreational users committing criminal acts. But leading international researchers and scholars who contributed to this book hold that the use of psychedelic substances for health, religious, intellectual, and artistic purposes is a Constitutional right—and a human right. Based on that conclusion, these scholars focus on policy issues that regulate the use of psychedelic drugs in medicine, religion, personal life, and higher education, arguing that existing regulations should match current and anticipated future uses. This volume has two parts. The first surveys research on the use of psychedelic drugs in medicine, religion, and truth-seeking, following these topics through history and contemporary practice. The second section treats government policices that regulate the psychological, physiological, biochemical, and spiritual aspects of research and experience in these fields. The Psychedelic Policy Quagmire: Health, Law, Freedom, and Society challenges medical and legal policy experts, ethicists, scientists, and scholars with the question: How can we formulate policies that reduce the dangers of psychedelics' misuse and at the same time maximize the emerging diverse benefits?
| Author | : Michael J. Winkelman |
| Publisher | : Bloomsbury Publishing USA |
| Total Pages | : 397 |
| Release | : 2019-03-22 |
| Genre | : Health & Fitness |
| ISBN | : 144086411X |
Researchers, program administrators, and practicing clinicians explain the most recent developments in using psychedelic substances to treat psychological, physiological, and social problems. More than a decade ago, the U.S. government lifted its ban on all testing of psychedelic substances. Winkelman and Sessa now provide updated scientific research and applications of these substances, now moving into approved categories of medicine. The text is an up-to-date assessment of the latest advances in the field of psychedelic medicine, covering the use of LSD, psilocybin, MDMA, ayahuasca, and other substances to augment psychotherapies for a range of disorders. It discusses medical and psychiatric concerns, clinical efficacy and safety, ethical considerations, and neuroscience findings regarding the psychedelic compounds. Topics covered include an overview of psychiatric applications of psychedelics; treatments for addictions and depressive disorders; effects of psychedelics on inflammation and neuroplasticity; evidence for clinical applications of DMT, ayahuasca, and cannabidiol; psychedelic treatment of sociopathic disorders; microdosing psychedelics; training psychedelic therapists; and community-based harm reduction approaches to managing psychedelic crises.
